IACS Capabilities
IACS has the expertise and capabilities to develop and shepherd new chemical matter and biotherapeutics from a target idea through clinical development in specific patient sub-populations. Seamlessly integrated project teams with diverse skills work together to conduct innovative program biology and drug discovery in parallel programs that result in effective novel therapies and a comprehensive understanding of the optimal clinical setting for their use.
Explore our capabilities (see links below or left navigation).
Learn more:
Cancer Genomics
Comprehensive Cancer Biology and Translational Medicine
Computational Biology
Computational Chemistry
Drug Metabolism and Pharmacokinetics
In Vivo Pharmacology
Lead Discovery and Biotesting
Medicinal Chemistry
Mouse Models of Human Cancer
Newsletter
March 2013
December 2012
Contact Us
Institute for Applied Cancer Science
MD Anderson Cancer Center
1901 East Road
Houston TX 77054
Tel: 713-745-2600
For questions concerning collaborations or partnerships, please contact:
Eric Devroe
Executive Director of Strategic Alliances
EJDevroe@mdanderson.org
We need your help
Philanthropic support will provide IACS several critical advantages that will ultimately benefit cancer patients by providing them with novel treatments in a shorter timeframe. If you’re interested in advancing this transformative venture, please donate through the myGiving site.